Company news
Callan JMB Inc. news in 2026
Callan JMB Inc.'s news releases, calls and decks from 2026, newest first.
Callan JMB CEO and Management Team Invest $1.5 Million in Common-Only Transaction at a Premium of $1.10 Per Share, Reinforcing Confidence in Growth Strategy
November 12, 2026
Callan JMB Announces Arrival of Rapid Dose Therapeutics’ QuickStrip™, Resulting in $15 Million in Projected Revenue Over the Next 18 months
November 2, 2026
Callan JMB to Break Ground on IV Bag Manufacturing Facility Fully Funded by Non-Dilutive and Non-Interest-Bearing Third-Party Partnership
October 22, 2026
Callan JMB Advances IV Bag Manufacturing Facility with Projected $450 Million in Annual Revenue
October 20, 2026
Callan JMB Advances U.S. Pharmaceutical Manufacturing at the Atlas Complex and Expands into North American Equipment Distribution and Assembly
October 8, 2026
Callan Power to Acquire Williston Basin Non-Operated Oil and Gas Assets with $48 Million Proved PV-10 and $83 Million 3P PV-10 from The Pfanenstiel Company, Significantly Expanding Energy Assets
August 27, 2026
Callan JMB Designates Andy Weigman to Join Callan Power's Oil and Gas Development Efforts; Weigman Brings Experience on More Than $1 Billion in Sourced Acquisition Opportunities and Extensive Williston Basin Operational Expertise
August 25, 2026
Callan JMB Retains Northern Oil and Gas Founder Michael Reger as President of Callan Power; Northern Oil and Gas Now Valued at Approximately $2.9 Billion
August 24, 2026
Callan JMB’s Callan Power to Acquire Reger Oil Assets in The Williston Basin; Northern Oil and Gas Former CEO and Founder Michael Reger Named President of Callan Power and Board Member
August 20, 2026
Callan JMB Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
August 17, 2026
Callan JMB, Bia Power Systems and Alabama State University Announce $60 Million Advanced Electrical Manufacturing Venture in Brewton, Alabama
August 11, 2026
Callan JMB Announces Formation of Callan Power to Advance Domestic Manufacturing of Critical Electrical Infrastructure
August 6, 2026
Callan JMB Expands Atlas Complex, Advances Recurring Infrastructure Services Business with Cavalry 1838 Equine Biosciences
August 4, 2026
Callan JMB and Alabama State University Break Ground on Atlas Complex, Launching an Unprecedented Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
July 28, 2026
Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
July 16, 2026
Callan JMB Inc. and Alabama State University Partner to Advance Workforce Development, Research, and Pharmaceutical Innovation at the Atlas Complex
July 8, 2026
Callan JMB Expands Oregon Public Health Support Capabilities Through State VFC Authorization
June 11, 2026
Callan JMB Expands Long-Standing Public Sector Infrastructure Engagement
May 20, 2026
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure
April 20, 2026
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
April 17, 2026
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
April 6, 2026
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update
March 30, 2026
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
March 26, 2026
DifGen Pharmaceuticals and Aveva Drug Delivery Systems Lead U.S. Technology Transfer and Platform Development Collaboration for Multi-Indication Immune Restoration Therapy with Active IND Programs and Phase 2b/3 Authorization in PASC
March 25, 2026
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID
March 10, 2026
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
March 9, 2026
iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026
March 3, 2026
Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026
March 1, 2026
Callan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10–11, 2026
February 26, 2026
Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026
January 20, 2026
Callan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue
January 15, 2026
Callan JMB Inc. (NASDAQ: CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility
January 12, 2026
Decks in 2026
- Investor Presentation (August 2026)
Investor deck · 20 slides · August 2026
- Investor Presentation (January 2026)
Investor deck · 20 slides · Jan 27, 2026